Crofelemer
Crofelemer is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including MYTESI. Available dosage forms: powder, tablet, coated.
Drug Details
- Generic Name
- Crofelemer
- Brand Names
- MYTESI
- Application Number
- NDA202292
- Sponsor
- Indena SpA
- NDC Codes
- 2
- Dosage Forms
- POWDER, TABLET, COATED
- Routes
- ORAL
- Active Ingredients
- CROFELEMER
Indications and Usage
1 INDICATIONS AND USAGE MYTESI is indicated for symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. MYTESI is an anti-diarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. ( 1 )